Clinical trials
Phase 4 Diabetes Mellitus, Type 2 trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi | 6 |
| Novo Nordisk A/S | 3 |
| AstraZeneca | 2 |
| GlaxoSmithKline | 2 |
| Novartis Pharmaceuticals | 2 |
| Boehringer Ingelheim | 1 |
| Bristol-Myers Squibb | 1 |
| Charles University, Czech Republic | 1 |
| Eli Lilly and Company | 1 |
| Gilead Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 21 |
| Diabetes Mellitus | 5 |
| Albuminuria | 1 |
| Angina Pectoris | 1 |
| Cardiovascular Diseases | 1 |
| Coronary Artery Disease | 1 |
| Heart Failure | 1 |
| Metabolic Diseases | 1 |
| Myocardial Infarction | 1 |
| Renal Insufficiency | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.